Biogeographic distribution and molecular epidemiology of Clostridioides (Clostridium) difficile in Western Australian soils

被引:3
作者
Cautivo-Reyes, Karla [1 ]
Knight, Daniel R. [2 ,3 ]
Bowie, Deborah [4 ]
Moreira-Grez, Benjamin [4 ]
Whiteley, Andrew S. [5 ]
Riley, Thomas V. [1 ,2 ,3 ,6 ]
机构
[1] Murdoch Univ, Harry Butler Inst, Biosecur & One Hlth Res Ctr, Perth, WA, Australia
[2] Univ Western Australia, Sch Biomed Sci, Perth, WA, Australia
[3] Queen Elizabeth II Med Ctr, PathWest Lab Med, Dept Microbiol, Nedlands, WA, Australia
[4] Univ Western Australia, Sch Agr & Environm Sci, Perth, Australia
[5] CSIRO, Land & Water, Canberra, Australia
[6] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia
基金
英国医学研究理事会;
关键词
Clostridioides (Clostridium) difficile; soils; ecology; Western Australia; molecular epidemiology; HIGH PREVALENCE; NEONATAL PIGS; INFECTION;
D O I
10.1128/aem.00379-23
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Clostridioides (Clostridium) difficile is a leading cause of infectious diarrhea in humans and production animals and can be found in a variety of environmental sources. The prevalence and diversity of multi-locus sequence type clade 5 strains of C. difficile in Australian production animals suggest Australia might be the ancestral home of this lineage of One Health importance. To better understand the role of the environment in the colonization of humans and animals in Australia, it is important to investigate these endemic sources. This study describes the prevalence, molecular epidemiology, and biogeographic distribution of C. difficile in soils of Western Australia. A total of 321 soil samples from remote geographical locations across the eight health regions of Western Australia were screened for C. difficile and isolates characterized by PCR ribotyping and toxin gene profiling. C. difficile was isolated from 31.15% of samples, with the highest prevalence in the Perth Metropolitan Health Region (49.25%, n = 33/67). Overall, 52 different strains [PCR ribotypes (RTs)] were identified, with 14 being novel, and 38% (38/100) of isolates being toxigenic, the most common of which was RT014/020. Five unique novel isolates showed characteristics similar to C. difficile clade 5. This is the first study of C. difficile isolated from soils in Australia. The high prevalence and heterogeneity of C. difficile strains recovered suggest that soils play a role in the survival and environmental dissemination of this organism, and potentially its transmission among native wildlife and production animals, and in community and hospital settings.
引用
收藏
页数:10
相关论文
共 44 条
  • [1] betapart: an R package for the study of beta diversity
    Baselga, Andres
    Orme, C. David L.
    [J]. METHODS IN ECOLOGY AND EVOLUTION, 2012, 3 (05): : 808 - 812
  • [2] Comparison of ChromID C. difficile agar and cycloserine-cefoxitin-fructose agar for the recovery of Clostridium difficile
    Boseiwaqa, Lusiana V.
    Foster, Niki F.
    Thean, Sara K.
    Squire, Michele M.
    Riley, Thomas V.
    Carson, Kerry C.
    [J]. PATHOLOGY, 2013, 45 (05) : 495 - 500
  • [3] Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers
    Brouwer, Michael S. M.
    Roberts, Adam P.
    Hussain, Haitham
    Williams, Rachel J.
    Allan, Elaine
    Mullany, Peter
    [J]. NATURE COMMUNICATIONS, 2013, 4
  • [4] A review of Clostridioides [Clostridium] difficile occurrence through the food chain
    Candel-Perez, Carmen
    Ros-Berruezo, Gaspar
    Martinez-Gracia, Carmen
    [J]. FOOD MICROBIOLOGY, 2019, 77 : 118 - 129
  • [5] CLSI, 2013, Methods for antimicrobial susceptibility testing of anaerobic bacteria
  • [6] approved standardseventh edition
  • [7] CLSI (Clinical and Laboratory Standards Institute), 2013, Performance standards for antimicrobial susceptibility test
  • [8] Linkage study of surveillance and hospital admission data to investigate Clostridium difficile infection in hospital patients in Perth, Western Australia
    Collins, Deirdre A.
    Marcella, Stephen
    Campbell, Michael
    V. Riley, Thomas
    [J]. ANAEROBE, 2022, 74
  • [9] Clostridium difficile in Asia: Opportunities for One Health Management
    Collins, Deirdre A.
    Riley, Thomas, V
    [J]. TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2019, 4 (01)
  • [10] EMA, 2011, Committee for medicinal products for human use (CHMP) EMA. Assessment report-Fidaxomicin